ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1928

Isolation and Initial Characterization of Dermal Vascular Smooth Muscle Cells in Systemic Sclerosis

Shadia Nada1, Farouk Abu Alhana2, Yongqing Wang2, Nezam Altorok3 and Bashar Kahaleh4, 1Internal Medicine, Divison of Rheumatology, The University of Toledo, Toledo, OH, 2The University of Toledo, Toledo, OH, 3Internal Medicine, Division of Rheumatology, The University of Toledo, Toledo, OH, 4Medicine/Rheumatology, The University of Toledo, Toledo, OH

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Raynaud's phenomenon, Scleroderma, systemic sclerosis and vasculogenesis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Nearly all patients with Systemic sclerosis (SSc) suffer from vascular dysfunction as illustrated by the uniform presence of Raynaud’s phenomena. The role of vascular smooth muscle cells (VSMCs) in the development of vascular dysfunction is still unknown. In this study, we isolated VSMCs from skin biopsy, and we examined their functional phenotype.

Methods: We obtained 4 mm punch-skin-biopsy from 3 patients with diffuse cutaneous SSc and 3 matched healthy controls. Skin specimens were treated with a mixture of proteases, then after digestion we plated cells in culture media and harvested the primary cell culture after 10 days. VSMCs were isolated by magnetic microbeads using cell surface markers. First, we depleted total cells from CD31+ cells, followed by positive selection for CD146 + cells. To confirm the identity of this cell population (CD31- CD146+), we performed immunoflorocytometry staining for smooth muscle myosin heavy chain 11 (MYH11), Desmin and NG2. We investigated cell proliferation by using Bromodeoxyuridine (BrdU) assay, and cell viability in normal culture conditions as well as low serum conditions using MTT assay.  

Results: Out of the total cells obtained from primary cell culture, 15% were CD31- CD146 + (VSMCs). The majority of cells in this population stained for smooth muscle MYH11 (89.1%), in addition to Desmin and NG2, while the CD31+ and the fibroblast cell populations did not. This staining pattern differentiates VSMCs from pericytes. Next, we evaluated cell proliferation using BrdU, and we demonstrated uptake of BrdU by 19% of the control-VSMCs compared to 34% of SSc-VSMCs (P= 0.0031). The MTT assay showed increase cell proliferation of SSc-VSMCs compared to control-VSMCs (0.44 and 0.25, respectively. P= 7.38E-08). Under serum starvation conditions, SSc-VSMCs exhibited more proliferation capacity than control-VSMCs (0.30 and 0.21, respectively. P= 5.73E-13). Also, we performed immunoflorocytometry staining for B-catenin and we demonstrate a cytoplasmic to nuclear translocation of B-catenin in SSc-VSMCs but not in control-VSMCs. This finding may imply potential involvement of B-catenin in the induction of VSMCs activation in SSc.

Conclusion: This is the first report of the successful isolation and initial characterization of  SSc-VSMCs. We believe that increased proliferation of SSc-VSMCs in association with resistance to apoptosis may greatly impact the vascular lesion in SSc. Further studies are warranted to fully understand the trigger and maintenance of  the abnormal SSc-VSMCs phenotype.


Disclosure: S. Nada, None; F. Abu Alhana, None; Y. Wang, None; N. Altorok, None; B. Kahaleh, None.

To cite this abstract in AMA style:

Nada S, Abu Alhana F, Wang Y, Altorok N, Kahaleh B. Isolation and Initial Characterization of Dermal Vascular Smooth Muscle Cells in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/isolation-and-initial-characterization-of-dermal-vascular-smooth-muscle-cells-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/isolation-and-initial-characterization-of-dermal-vascular-smooth-muscle-cells-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology